Specific components of NADH‐ubiquinone oxidoreductase (Nduf) were upregulated, including core subunit V2 (Ndufv2), which is known to protect against doxorubicin‐induced mitochondrial dysfunction‐driven cardiomyopathy [18]. The gene discussed is NDUFV2; the disease is cardiomyopathy.